Clinical Trials Browser

Phase 1 × ceralasertib × Tumor-Agnostic × Clear all

NCT02630199 2022-06-15

Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory Cancer

Phase 1 Completed

Neoplasms

NCT03669601 2021-06-04

ATRiUM

Phase 1 Unknown

Neoplasm Metastasis, Neoplasms